Cargando…

Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors

SIMPLE SUMMARY: Colorectal cancer (CRC) incidence is increasing worldwide and represents an important health problem.Therapy failure and progression to metastatic disease are major concerns. Among the factors involved in tumor growth, galectin-3 (Gal-3) plays an important role due to its ability to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aureli, Anna, Del Cornò, Manuela, Marziani, Beatrice, Gessani, Sandra, Conti, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817985/ https://www.ncbi.nlm.nih.gov/pubmed/36612048 http://dx.doi.org/10.3390/cancers15010052

Ejemplares similares

Innate Lymphocytes in Adipose Tissue Homeostasis and Their Alterations in Obesity and Colorectal Cancer
por: Del Cornò, Manuela, et al.
Publicado: (2018)

Linking Diet to Colorectal Cancer: The Emerging Role of MicroRNA in the Communication between Plant and Animal Kingdoms
por: Del Cornò, Manuela, et al.
Publicado: (2017)

Shaping the Innate Immune Response by Dietary Glucans: Any Role in the Control of Cancer?
por: Del Cornò, Manuela, et al.
Publicado: (2020)

Type I Interferons as Regulators of Human Antigen Presenting Cell Functions
por: Gessani, Sandra, et al.
Publicado: (2014)

Transcriptome Profiles of Human Visceral Adipocytes in Obesity and Colorectal Cancer Unravel the Effects of Body Mass Index and Polyunsaturated Fatty Acids on Genes and Biological Processes Related to Tumorigenesis
por: Del Cornò, Manuela, et al.
Publicado: (2019)

Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer
por: Donninelli, Gloria, et al.
Publicado: (2017)

Integrated Transcriptome Analysis of Human Visceral Adipocytes Unravels Dysregulated microRNA-Long Non-coding RNA-mRNA Networks in Obesity and Colorectal Cancer
por: Tait, Sabrina, et al.
Publicado: (2020)

Dietary Polyphenols: Promising Adjuvants for Colorectal Cancer Therapies
por: Bracci, Laura, et al.
Publicado: (2021)

Visceral fat adipocytes from obese and colorectal cancer subjects exhibit distinct secretory and ω6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells
por: Del Cornò, Manuela, et al.
Publicado: (2016)

Dietary Fatty Acids at the Crossroad between Obesity and Colorectal Cancer: Fine Regulators of Adipose Tissue Homeostasis and Immune Response
por: Del Cornò, Manuela, et al.
Publicado: (2021)

HIV-1 gp120 influences the expression of microRNAs in human monocyte-derived dendritic cells via STAT3 activation
por: Masotti, Andrea, et al.
Publicado: (2015)

Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond
por: Aureli, Anna, et al.
Publicado: (2023)

Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their Monocyte Precursors
por: Latorre, Daniela, et al.
Publicado: (2015)

Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia
por: Aureli, Anna, et al.
Publicado: (2021)

Immune Dysfunctions and Immunotherapy in Colorectal Cancer: The Role of Dendritic Cells
por: Gessani, Sandra, et al.
Publicado: (2019)

Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
por: Leung, Zoe, et al.
Publicado: (2019)

Editorial: Diet, Inflammation and Colorectal Cancer
por: Gessani, Sandra, et al.
Publicado: (2019)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
por: Chaudhary, Sapana, et al.
Publicado: (2022)

ω3 Polyunsaturated Fatty Acids as Immunomodulators in Colorectal Cancer: New Potential Role in Adjuvant Therapies
por: Miccadei, Stefania, et al.
Publicado: (2016)

Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
por: Traber, Peter G., et al.
Publicado: (2013)

IgE-immunoadsorption for severe allergy to multiple foods: A case series of five children
por: Arasi, Stefania, et al.
Publicado: (2023)

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis
por: Duckworth, Carrie A., et al.
Publicado: (2015)

Design, Synthesis, and Anticancer Activity of a Selenium-Containing Galectin-3 and Galectin-9N Inhibitor
por: Di Gaetano, Sonia, et al.
Publicado: (2022)

Direct and Intestinal Epithelial Cell-Mediated Effects of TLR8 Triggering on Human Dendritic Cells, CD14(+)CD16(+) Monocytes and γδ T Lymphocytes
por: Angelini, Costanza, et al.
Publicado: (2017)

Human galectin-1 and galectin-3 promote Tropheryma whipplei infection
por: Ayona, Diyoly, et al.
Publicado: (2021)

Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Clementy, Nicolas, et al.
Publicado: (2018)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

Therapeutic implications of galectin-3 in patients with atrial fibrillation
por: Lee, Kwang-No, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Synthesis of tricyclic carbohydrate–benzene hybrids as selective inhibitors of galectin-1 and galectin-8 N-terminal domains
por: Wu, Chunxia, et al.
Publicado: (2020)

Extracellular and intracellular small-molecule galectin-3 inhibitors
por: Stegmayr, John, et al.
Publicado: (2019)

Therapeutic prevention of colorectal carcinogenesis
por: Meyskens, Frank L.
Publicado: (2011)

Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)
por: Hutter, Stefan, et al.
Publicado: (2016)

ESMO 2021—highlights in colorectal cancer
por: Weiss, Lukas
Publicado: (2022)

Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019)

Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis
por: Sun, Jiao, et al.
Publicado: (2021)

Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives
por: Li, Chien-Hsiu, et al.
Publicado: (2021)

Galectin-3 Involvement in Cognitive Processes for New Therapeutic Considerations
por: Mijailović, Nataša R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0saidof1qtfn59r4s9a1249361